SHA:600812

2 stories mentioning SHA:600812Updated 22d ago

Every FINWIRES story that references SHA:600812, newest first.

North China Pharmaceutical's Eight Products Win Preliminary Bids Under Government Drug Procurement Program

North China Pharmaceutical's (SHA:600812) eight products won preliminary bids under China's drug procurement program, according to a Tuesday disclosure to the Shanghai Stock Exchange.Two of the drugs, cyclosporine and tacrolimus capsules, are indicated for transplant patients, while edoxaban tosilate is an anticoagulant.The other five products, teicoplanin, vancomycin hydrochloride, isavuconazonium sulfate, ceftazidime and avibactam sodium, and imipenem and cilastatin sodium, are all antibiotic injections.

SHA:600812

Asia94d ago

North China Pharma Gets China Nod for Kidney Anemia Drug

North China Pharmaceutical (SHA:600812) obtained drug registration from China's medical products regulator for its roxadustat tablets.The drug is used to treat renal anemia caused by chronic kidney disease, according to a weekend filing with the Shanghai bourse.Shares of the pharmaceutical company closed 1% lower Monday.

SHA:600812

Track with the FINWIRES app suite

FolioX

Track SHA:600812 in your portfolio

WheelAI

Analyze SHA:600812 options with the wheel strategy

StockInsider

See market sentiment on SHA:600812